Skip to main content

RU486: After Ten Years Novel Molecules and Reproductive Medicine

  • Chapter
  • 119 Accesses

Part of the book series: Reproductive Biology ((RBIO))

Abstract

The story of RU486* (Figure 1) may be seen as the combined result of the women’s movement during the 20th century to control their reproductive life and the contemporary scientific bio medical revolution of the last few decades.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Avrech, O.M., Bukovsky, I., Golan, A., Caspi, E., and Weinraub, Z., 1991, Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Fertil. Steril. 56:385–393.

    PubMed  CAS  Google Scholar 

  • Baird, D. T., Rodger, M., Cameron, I.T., and Roberts, I., 1988, Prostaglandins and antiestrogens for the interruption of early pregnancy. J. Reprod Fertil. 36:173–179.

    CAS  Google Scholar 

  • Baldi, E., Casano, R., Falsetti, C., Krausz, C., Maggi, M and Forti, G., 1991, Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J. Androl. 12:323–330.

    PubMed  CAS  Google Scholar 

  • Batista, M.C., Bristow, T.L., Mathews, J., Stokes, W.S, Loriaux, D.I., and Nieman, L.D., 1991, Daily administration of the progesterone antagonist RU486 prevents implantation in the cycling guinea pig. Am. J. Obstet. Gynecol 165:82–86

    PubMed  CAS  Google Scholar 

  • Batista, M.C., Cartledge, T.P., Zellmer, A.W., Nieman, L.K., Merriam, G.R., and Loriaux, D.L., 1992, Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation. J. Clin. Endocrinol. Metab. 74:565–570.

    Article  PubMed  CAS  Google Scholar 

  • Baulieu, E.E., 1975, Antiprogesterone effect and midcycle (periovulatory) contraception. Eur. J. Obstet. Gynecol. Reprod. Biol. 4:161–166

    Article  PubMed  CAS  Google Scholar 

  • Baulieu, E.E., 1985, RU486: an antiprogestin steroid with contragestive activitiy in women, in: “The Antiprogestin Steroid RU486 and Human Fertility Control”, E.E. Baulieu, and S.J. Segal, eds, Plenum Press, New York

    Chapter  Google Scholar 

  • Baulieu, E.E., and Segal, S.J., 1985, “The Antiprogestin Steroid RU486 and Human Fertility Control”. Plenum Press, New York and London.

    Book  Google Scholar 

  • Baulieu, E.E., 1989a, Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 245:1351–1357.

    Article  PubMed  CAS  Google Scholar 

  • Baulieu, E.E., 1989b, RU486 as an antiprogeslerone steroid, from receptor to contragestion and beyond. J. Am Med. Assuc. 262:1808–1814.

    Article  CAS  Google Scholar 

  • Baulieu, E.E., 1991a, RU486 and the early nineties Adv. Contracept. 7:345–351.

    Article  CAS  Google Scholar 

  • Baulieu, E.E, 1991b, The Antisteroid RU486 Its cellular and molecular mode of action. Trends Endocrinol. Metab. 2:233–239.

    Article  PubMed  CAS  Google Scholar 

  • Baulieu, E.E, 1991c, “The Abortion Pill”, Simon & Schuster, New York.

    Google Scholar 

  • Bélanger, A., Philibert, D., and Teutsch, G., 1981, Regio and stereospecific synthesis of 11 β-substitution on progesterone receptor affindty. Steroids 37:361–383.

    Article  PubMed  Google Scholar 

  • Benhamou, B., Garcia, T., Lerouge, T., Vergezae, A., Gofflo, D., Bigogne, C., Chambon, P. and Gronemeyer, II., 1992, A single amino acid that determines the sensitivity of progesterone receptors to RU486. Science 255:206–209.

    Article  PubMed  CAS  Google Scholar 

  • Bergström, S., Diczfalusy, E., Boreil, U., Karim, S., Samuelson, B., Uvnas, B., Wiqvist, N., and Bygdeman, M., 1972, Prostaglandins in fertility control Science 175:1280–1287.

    Article  PubMed  Google Scholar 

  • Bertagna, X., Bertagna, C., Luton, J.P., Husson, J.M., and Girard, F., 1984, The new steroid analog RU486 inhibits glucocorticoid action in man. J. Clin. Endocrinol. Metab. 59:25–38.

    Article  PubMed  CAS  Google Scholar 

  • Birgerson, L., and Odlind, V., 1987, Early pregnancy termination with antiprogestins: a comparative clinical study of RU486 given in two dose regimens and Epostane. Fertil. Steril. 48:565–570.

    PubMed  CAS  Google Scholar 

  • Blackmore, P.F., Neulen, J., Lattanzio, F., and Beebe, S.J. 1991, Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J. Biol. Chem. 266:18655–18659.

    PubMed  CAS  Google Scholar 

  • Blondeau, J.P, and Baulieu, E.E., 1985, Progesterone inhibited phosphorylation of an unique Mr 48,000 protein in the plasma membrane of Xenopus laevis oocytes. J. Biol. Chem. 260:3617–3625.

    PubMed  CAS  Google Scholar 

  • Bosc, M.J., Germain, G., Nicolle, A. Philibert, D., and Baulieu, E.E., 1985, The use of antiprogesterone compound RU486 to control timing of parturition in rats. in: “The Antiprogestin Steroid RU486 and Human Fertility Control”, E.E. Baulieu, and S.J. Segal, eds., Plenum Press, New York.

    Google Scholar 

  • Brogden, R.N., Goa, K.L., and Faulds, D., 1993, Mifepristone: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs 45:384–409.

    Article  PubMed  CAS  Google Scholar 

  • Bucourt, R., Vignau, M., Torelli, V., Richard Foy, H., Geynet, C., Secco-Millet, C., Redeuilh, G., and Baulieu, E.E., 1978, New biospecific adsorbents for the purification of estradiol receptor. J. Biol. Chem. 25:8221–8228.

    Google Scholar 

  • Bygdeman, M., and Swahn, M.L., 1985, Progesterone receptor blockage: effect on uterine contractility and early pregnancy Contraception 32:45–51.

    Article  PubMed  CAS  Google Scholar 

  • Cabrol, D., Bouvier d’Yvoire, M., Mermet, E., Cedard, L., Sureau, C., and Baulieu, E.E., 1985, Induction of labour with mifepristone after intrauterine fetal death. Lancet 8462:1019.

    Article  Google Scholar 

  • Cohn, M., and Stewart, P., 1991, Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study. Br. J. Obstet. Gynaecol. 98:778–782.

    Article  PubMed  CAS  Google Scholar 

  • Collins, R.L., and Hodgen, G.D., 1986, Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU486. A progesterone antagonist? J. Clin. Endocrin. Metab. 63:1270–1276.

    Article  CAS  Google Scholar 

  • Cook, C.E., Wani, M.C., Lee, Y-W., Fail, P.A., and Petrow, V., 1992, Reversal of activity profile in analogs of the antiprogestin RU486: effect of a 16α-substituent of progestational (agonist) activity. Life Sci. 52:155–162.

    Article  Google Scholar 

  • Cook, R.J., and Grimes, D.A., 1992, Antiprogestin Drugs: Ethical, Legal and Medical Issues. Law, Medicine & Health Care 20 (3).

    Google Scholar 

  • Corner, G.W., 1963, “The Hormones in Human Reproduction”, Athenum, New York.

    Google Scholar 

  • Couzinet, B., Le Strat, N., Ulmann, A., Baulieu, E.E, and Schaison, G., 1986, Termination of early pregnancy by the progesterone antagonist RU486 (mifepristone). New Engl. J. Med. 315:1565–1570.

    Article  PubMed  CAS  Google Scholar 

  • Crooij, M.J., and Janssens, J., 1988, Termination of early pregnancy by the 3β-hydroxysteroid dehydrogenase inhibitor epostane. New Engl. J. Med. 319, 813–817.

    Article  PubMed  CAS  Google Scholar 

  • Croxatto, H.B., and Salvatierra., 1991, Cyclic use of antigestagens for fertility control. in: “Female Contraception and Male Fertility Regulation”, B. Runnebaum, T. Rabe, and L. Kiesel, eds., The Parthenon Publishing Group, Casterton.

    Google Scholar 

  • Croxatto, H.B., Salvatierra, A.M., Croxatto, H.D., and Fuentealba, B., 1993, Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum. Reprod. 8:201–207.

    PubMed  CAS  Google Scholar 

  • Csapo, A.I., and Pulkkinen, M.O, 1977, Control of human parturition. in: “Progress in Perinatology”, H.A. Kaminelzky, and L. Iffy, eds., G.F. Stickley Company, Philadelphia.

    Google Scholar 

  • Danforth, D.R., Dubois, C., Ulmann, A., Baulieu, E.E., and Hodgen, G.D., 1989, Contraceptive potential of RU486 by ovulation inhibition. III. Preliminary observations on once weekly oral administration. Contraception 40:195–200.

    Article  PubMed  CAS  Google Scholar 

  • Djerassi, C., 1970, Birth control after 1984 Science 169:941–951.

    Article  PubMed  CAS  Google Scholar 

  • Dubois, C., Ulmann, A., Aubeny, F., Elia, D., Jourdan, M.C., Van Den Bosch, M.C., Leton, M., and Baulieu, E.E., 1988a, Contragestion par le RU486: intérêt de l’association à un dérivé prostaglandine. C. R. Acad Sci. Paris 306:57–61.

    PubMed  CAS  Google Scholar 

  • Dubois, C., Ulmann, A., and Baulieu, E. E., 1988b, Contragestion with late luteal administration of RU486 (Mifepristone). Fertil. Steril. 50:593–596.

    PubMed  CAS  Google Scholar 

  • El Alj, A., Breuiller, M., Jolivet, A., Ferre, F., and Germain, G., 1989, β2-adrenoceptor response in the rat uterus at the end of gestation and after induction of labor with RU486. Can. J. Physiol. Pharmacol. 67:1051–1057.

    Article  PubMed  Google Scholar 

  • El-Refaey, H., Hinshaw, K., Henshaw, R., Smith, and Templeton, A., 1992, Medical management of missed abortion and anembryonic pregnancy. Br. Med. J. 305:1399.

    Article  CAS  Google Scholar 

  • Frydman, R., Baton, C., Lelaidier, C., Fernandez, H., Vial, M., and Bourget, P., 1991, Mifepristone for induction of labour. Lancet 337:488–489.

    Article  PubMed  CAS  Google Scholar 

  • Frydman, R., Lelaidier, C., Baton Saint Mleux, C., Fernandez, H., Vial, M., and Bourget, P., 1992, Labor induction in women at term with mifepristone (RU486): a double-blind randomized, placebo controlled study. Obstet. Gynecol. 80:972–975.

    PubMed  CAS  Google Scholar 

  • Gaillard, R.C., Riondel, A., Muller, M.F., Herrmann, W., and Baulieu, E.E., 1984, RU486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc. Natl. Acad. Sci. USA 81:3879–3882.

    Article  PubMed  CAS  Google Scholar 

  • Garcia, T., Benhamou, B, Gofflo, D., Vergezac, A., Philibert, D., Chambon, P., and Gronemeyer, H., 1992, Switching agonistic, antagonistic, and mixed transcriptional responses to 11β-substituted progestins by mutation of the progesterone receptor. Mol. Endocrinol 6:2071–20

    Article  PubMed  CAS  Google Scholar 

  • Garfield, R.F., Gasc, J.M., and Baulieu, E.E., 1987, Effects of the antiprogesterone RU486 on preterm birth in the rat. Am. J. Obstet Gynecol. 157:1281–1285.

    PubMed  CAS  Google Scholar 

  • Gemzell-Danielsson, K., Swahn, M.L., Svalander, P., and Bygdeman, M., 1993, Early luteal phase treatment with RU486 fertility regulation. (submitted).

    Google Scholar 

  • Ghosh, D., De, P., and Sengupta, J., 1992, Effect of RU486 on the endometrial response to deciduogenic stimulus in ovariectomized rhesus monkeys treated with oestrogen and progesterone. Hum. Reprod. 7:1048–1060.

    PubMed  CAS  Google Scholar 

  • Glasier, A., Thong, K.J., Dewar, M., Mackie, M., and Baird, D.T., 1992, Mifepristone (RU486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. New Engl. J. Med. 327:1041–1044.

    Article  PubMed  CAS  Google Scholar 

  • Graham, R.A., Aplin, J.D., Li, T-C., Cooke, I.D., and Seif, M.W., 1991, The effects of the antiprogesterone RU486 (Mifepristone) on an endometrial secretory glycan: an immunocytochemical study. Fertil Steril 55: 1132–1136.

    PubMed  CAS  Google Scholar 

  • Greene, K.E., Kettel, L.M., and Yen, S.S.C., 1992, Interruption of endometrial maturation without hormonal changes by un antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. Fert. Steril. 58:338–343.

    CAS  Google Scholar 

  • Grimaldi, B., Barre, J., and Tillement, J.P., 1992, Les rôles respectifs des liaisons aux protéines sanguines et tissulaires de la mifepristone (RU486) dans sa distribution quantitative dans l’organisme C. R. Acad. Sci. Paris 315:93–99

    PubMed  CAS  Google Scholar 

  • Grimes, D.A., 1992, Mifepristone (RU486) an abortifacient to prevent abortion? New Engl. J. Med. 327:1088–1089.

    Article  PubMed  CAS  Google Scholar 

  • Grimes, D.A., Mishell, D.R, and David, H.P., 1992, A randomized clinical trial of Mifepristone (RU486) for induction of delayed menses: efficacy and acceptability. Contraception 46:1–10.

    Article  PubMed  CAS  Google Scholar 

  • Groyer, A., Le Bouc, Y., Joab, I., Radanyi, C., Renoir, J.M., Robel, P., and Baulieu, E.E., 1985, Chick oviduct glucoeorticosteroid receptor. Specific binding of RU486 and immunological studies with antibodies to chick oviduct progesterone receptor. Eur. J. Blechem 149:445–451.

    Article  CAS  Google Scholar 

  • Gupta, J.K., and Johnson, N., 1992, Should we use prostaglandins, tents or progesterone antagonists for cervical ripening before first trimester abortion? Contraception 46:489–497.

    Article  PubMed  CAS  Google Scholar 

  • Haluska, G.J., Stanczyk, F.Z., Cook, M.J., and Novy, M.J., 1987, Temporal changes in uterine activity and prostaglandin response to RU486 in rhesus macaques in late gestation. Am. J. Obstet. Gynecol. 157:1487–1495.

    PubMed  CAS  Google Scholar 

  • Hegele Hartung, C., Mootz, U., and Beier, H.M., 1992, Luieal control of endonietrial receptivity and its modification by progesterone antagonists. Endocrinology 131:2446–2460.

    Article  Google Scholar 

  • Henderson, D., 1987, Antiprogestalional and antiglucocorticoid activities of some novel 11β-aryl substituted steroids in: “Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action”, F.J.A. Furt, and A.E. Wakeling, eds., Baillière Tindall, London.

    Google Scholar 

  • Hendry, L.B., and Mahesh, V.-B., 1992, Stereochemical complementarity of progesterone, RU486 and cavities between base pairs in partially unwound double stranded DNA assessed by computer modeling and energy calculations. J. Steroid Biochem. Mol. Biol. 41:647–651.

    Article  PubMed  CAS  Google Scholar 

  • Henshaw, U.C., and Templeton A.A., 1991, Pre-operative cervical preparation before first trimester vacuum aspiration a randomized controlled comparision between gemeprost and mifepristone (RU486) Br. J. Obstet. Gynaecol. 98:1025–1030.

    Article  PubMed  CAS  Google Scholar 

  • Herrmann, W., Wyss, R., Riondel, A., Philibert, D., Teutsch, G., Sakiz, E., and Baulieu, E.E., 1982, Effet d’un stéroïde anti progesterone chez la femme: interruption du cycle menstruel et de la grossesse au debut C. R. Acad. Sci. Paris 294:933–938.

    CAS  Google Scholar 

  • Horwitz, K.B., 1992, The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endoer Rev. 13:146–163.

    CAS  Google Scholar 

  • Hospital, M., Busetta, B., Bucourt, R., Weintraub, H., and Baulieu, E.E., 1972, X ray crystallography of estrogens and their binding to receptor sites. Mol. Pharmacol. 8:438–445.

    PubMed  CAS  Google Scholar 

  • Jensen, E.V., and Jacobson, H.I., 1962, Basic guides to the mechanism of estrogen action, in: “Recent Progress in Hormone Research”, G l’incus, ed., Academic Press, New York and London.

    Google Scholar 

  • Kovács, L., and Falkay, G., 1993, Changes in adrenergic receptors in the pregnant human uterine cervix following mifepristone or placebo treatment in the first trimester. Hum. Reprod. 8:119–121.

    PubMed  Google Scholar 

  • Lähteenmäki, P., Rapeli, T., Kääriäinen, M., Alfthan, H., and Ylikorkala, O., 1988, Late postcoital treatment against pregnancy with antiprogesterone RU486. Fertil. Steril. 50:36–38.

    PubMed  Google Scholar 

  • Laue, L., Kawai, Udelsman, R., Nieman, I. K., Brandon, D.D., Gallucci, W.T., Gold, P.W., Loriaux, D.L., and Chrousos, G.P., 1989, Glucocorticoid antagonists: pharmacological attributes of a prototype antiglucocorticoid (RU486). in: “Anti-inflammatory Steroid Action Basic and Clinical Aspects”. Academic Press, New York.

    Google Scholar 

  • Ledger, W.L., Sweeting, V.M., Millier, H and Baird, D.T., 1992, Inhibition of ovulation by low-dose mifepristone (RU486). Hum Reprod. 7:945–950.

    PubMed  CAS  Google Scholar 

  • Li, Y., Perezgrovas, R., Gazal, O.S., Schwabe, C., and Anderson, L.L., 1991, Antiprogesterone, RU486, facilitates parturition in cattle Endocrinology 129:765–770.

    Article  PubMed  CAS  Google Scholar 

  • Lieberman, S., Erlanger, B.F., Beiser, S.M., and Agate, F.J. Jr., 1959, Steroid-protein conjugates: their chemical, immunochemicai, aiul endocrinological properties, in: “Recent Progress in Hormone Research”, G. Pincus, ed., Academic Press, New York and London.

    Google Scholar 

  • Liu, J.H., Garzo, G., Morris, S., Stuenkel, C., Ulmann, A., and Yen, S.S.C., 1987, Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486. J. Clin. Endocrinol. Metal. 65:1135–1140.

    Article  CAS  Google Scholar 

  • Luukkainen, T., Heikinheimo, O., Haukkamaa, M., and Lahtcenmaki, P., 1988, Inhibition of folliculogenesis and ovulation by the antiprogesterone RU486. Fertil. Steril. 49:961–963.

    PubMed  CAS  Google Scholar 

  • Mao, J., Regelson, W., and Kalimi, M., 1992, Molecular mechanism of RU486 action: a review. Mol. Cell. Biochem. 109:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Milgrom, E., Alger, M., and Baulieu, E.E., 1970, Progesterone in uterus plasma. IV Progesterone receptor(s) in guinea pig uterus cytosol. Steroids 16:741–754.

    Article  PubMed  CAS  Google Scholar 

  • Mizutani, T., Bhakta, A., Kloosterboer, H.J., and Moudgil, V.K., 1992, Novel antiprogestins ORG31806 and 31710. interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes. J. Steroid Biochem. Mol. Biol. 42:695–704.

    Article  PubMed  CAS  Google Scholar 

  • Moguilewsky, M., and Philibert, D., 1985, Biochemical profile of RU486. in: “The Antiprogestin Steroid RU486 and Human Fertility Control”, E.E. Baulieu, and S.J. Segal, eds., Plenum Press, New York.

    Google Scholar 

  • Nath, R., Bhakta, A., and Moudgil, V.K. 1991, ZK98299 a new antiprogesterone: biochemical characterization of steroid binding parameters in the: calf uterine cytosol. Arch. Biochem Biophys. 292:303–310.

    Article  Google Scholar 

  • Nedelec, L., and Gase, J.C., 1970, Alcoylation angulaire par condensation des organo magnésiens sur les époxy-5,10 estrènes-9(11) Bull. Societe Chim. F. 2556-2564.

    Google Scholar 

  • Neef, G., Beier, S., Elger, W., Henderson, and Wiechert, R., 1984, New steroids with antiprogestational and antiglucocorticoid activities. Steroids 44:349–372.

    Article  PubMed  CAS  Google Scholar 

  • Neef, G., 1987, Antiprogestins. A new approach to contraception, in: “Trends in Medicinal Chemistry”, E. Mutschier, and K. Winterfeldt, eds., VCH, Veinheim.

    Google Scholar 

  • Parinaud, J., Labal, B., and Vieitez, G., 1992, High progesterone concentrations induce acrosome reaction with a low cytotoxic effect. Fertil. Steril. 58:599–602.

    PubMed  CAS  Google Scholar 

  • Peyron, R., Aubény, E., Targosz, V., Silvestre, L., Renault, M., Elkik, F., Leclerc, P., Ulmann, A., and Baulieu, E.E., 1993, Early pregnancy interruption with mifepristone (RU486) and the orally active prostaglandin misoproslol. New Engl. J. Med. 328:1509–1513.

    Article  PubMed  CAS  Google Scholar 

  • Philibert, D., Costerousse, G., Gaillard-Moguilewsky, M., Nedelec, L., Nique, F., Tournemine, C., and Teutsch, G., 1991, From RU38486 towards dissociated antiglucocorticoid and antiprogeste rone, in: “Antihormones in Health and Disease”, M.K. Agarwal, ed., Karger, Basel.

    Google Scholar 

  • Pincus, G, 1965, “The Control of Fertility”, Academic Press, New York and London.

    Google Scholar 

  • Rådestad, A., and Bygdeman, M., 1992, Cervical softening with mifepristone (RU486) after pretreatment with naproxen. A double blind randomized study. Contraception 45:221–227.

    Article  PubMed  Google Scholar 

  • Rodger, M.W., and Baird, D.T., 1990, Pretreatment with mifepristone (RU486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br. J. Obstet Gynaecol. 97:41–45.

    Article  PubMed  CAS  Google Scholar 

  • Rotello, R.J., Lieberman, R.C., Lepoff, R.B., and Gerschenson, L.E., 1992, Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU486. Am. J. Pathol. 140:449–456.

    PubMed  CAS  Google Scholar 

  • Shoupe, D., Mishell, D.R., Page, M.A., Madkour, H., Spitz, I.M, and Lobo, R.A., 1987, Effects of an anti progesterone RU486 in normal women. II. Administration in the late follicular phase. Am. J. Obstet. Gynecol 157:1421–1426

    PubMed  CAS  Google Scholar 

  • Sutherland, R., Mester, J., and Baulieu, E.E., 1977, Tamoxifen is a potent “pure” anti-oestrogen in chick oviduct. Nature 267:434–435.

    Article  PubMed  CAS  Google Scholar 

  • Swahn, M.L. and Bygdeman, M., 1988, The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br, J. Obstet. Gynaecol. 95:126–134.

    Article  CAS  Google Scholar 

  • Teutsch, G., and Bélanger, A., 1979, Regio and stereospecific synthesis for 11β-substituted 19-norsteroids. Tetrahedron Lett. 22:2051–2054.

    Article  Google Scholar 

  • Teutsch, G., Ojasoo, T., and Raynaud, J.P, 1988, 11β-substituted steroids, an original pathway to antihonnones. J. Steroid Biochem 31:549–565.

    Article  PubMed  CAS  Google Scholar 

  • Thong, K.J., and Baird, D.T., 1992, A study of Gemeproat alone, Dilapan or Mifepristone in combination with Gemeprost for the termination of second trimester pregnancy. Contraception 46:11–17.

    Article  PubMed  CAS  Google Scholar 

  • Thong, K.J., Dewar, M.H., and Baird, D.T., 1992, What do women want during medical abortion? Contraception 46:435–442.

    Article  PubMed  CAS  Google Scholar 

  • Uhler, M.L., Leung, A., Chan, S.Y.W., and Wang, C., 1992, Direct effects of progesterone and antiprogesterone on human sperm hyperactivated motility and acrosome reaction. Fertil. Steril. 58:1191–1198.

    PubMed  CAS  Google Scholar 

  • Ulmann, A., Teutsch, G., and Philibert, D., 1990, RU486. Scient. Am. 262:18–24.

    Article  Google Scholar 

  • Ulmann, A., Silvestre, L., Chemama, L., Rezvani, Y., Renault, M., Aguillaume, C.J., and Baulieu, E.E., 1992, Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue: study in 16,369 women. Acta Obstet. Gynecol. Scand. 71:278–283.

    Article  PubMed  CAS  Google Scholar 

  • Urquhart, D.R., and Templeton, A.A., 1990, Mifepristone (RU486) for cervical priming prior to surgically induced abortion in the late first trimester. Contraception 42:191–199.

    Article  PubMed  CAS  Google Scholar 

  • Van Santen, M.R., and Haspels, A.A., 1987, Failure of mifepristone (RU486) as a monthly contragestive, “Lunarette”. Contraception 35:433–438.

    Article  PubMed  Google Scholar 

  • Wakeling, A.E., and Bowler, J., 1988, Novel antioestrogens without partial agonist activity. J. Steroid Biochem. 31:645–659.

    Article  PubMed  CAS  Google Scholar 

  • Wang, W.M., Heap, R.B., and Taussig, M.J., 1989, Blocking of pregnancy in mice by immunization with anti-idiotype directed against monoclonal anti-progesterone antibody. Proc. Natl. Acad. Sci. USA 86:7098–7102.

    Article  PubMed  CAS  Google Scholar 

  • Webb, A.M.C., Russell, J., and Elstein, M., 1992, Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception. Br. Med. J. 305:927–931.

    Article  CAS  Google Scholar 

  • Weinstein, M.A., Pleim, E.R., and Barfield, R.J., 1991, Effects of neonatal exposure to the antiprogestin mifepristone, RU486, on the sexual development of the rat. Pharmacol. Biochem Behav. 41:69–74.

    Article  Google Scholar 

  • Wolf, J.P., Chillik, C.F., Itskovitz, J., Weyman, D., Anderson, T.L., Ulman, A., Baulieu, E.E., and Hodgen, G.D., 1988, Transplacental passage of a progesterone antagonist in monkeys. Am. J. Obstet. Gynecol. 159:238–242.

    PubMed  CAS  Google Scholar 

  • Wolf, J.P., Sinosich, M., Anderson T.L., Ulmann, A., Baulieu, E.E., and Hodgen, G.D., 1989, Progesterone antagonist (RU 486) for cervical dilatation, labor induction, and delivery in monkeys: effectiveness in combination with oxytocin. Am. J. Obstet. Gynecol. 160:45–47.

    PubMed  CAS  Google Scholar 

  • Wolf, J.P., Chillik, C.F., Dubois, C., Ulmann, A., Baulieu, E.E., and Hodgen, G.D., 1990, Tolerance of perinidatory primate embryos to RU486 exposure in vitro and in vivo. Contraception 41: 85–92.

    Article  PubMed  CAS  Google Scholar 

  • Wolf, J.P., Simon, J., Itskovitz, J., Sinosich, M.J., Ulman, A., Baulieu, E.E., and Hodgen, G.D., 1993, Progesterone antagonist RU486 accommodates but does not induce labor and delivery in primates. Hum Reprod. 8:759–763.

    PubMed  CAS  Google Scholar 

  • Wu, J.T., 1992, Failure of corticosterone (B) and progesterone (P) to reverse the inhibitory effect of RU486 (RU) on the development of two cell mouse embryos in vitro. Biol. Reprod. 46:77, Abstract 106.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Baulieu, EE. (1994). RU486: After Ten Years Novel Molecules and Reproductive Medicine. In: Glasser, S.R., Mulholland, J., Psychoyos, A. (eds) Endocrinology of Embryo-Endometrium Interactions. Reproductive Biology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1881-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1881-5_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5766-7

  • Online ISBN: 978-1-4615-1881-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics